SCHEMBL21362694

SCHEMBL21362694

CCS(=O)(=O)Cc1ccc(C(=O)c2ccc(C)cc2F)c(-c2cn(C)c(=O)cc2CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 6/20 0.34
MAP2K2 P36507 3/20 0.33
MAP2K1 Q02750 3/20 0.33
PDE10A Q9Y233 2/20 0.33
HDAC10 Q969S8 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
RAF1 P04049 1/20 0.32
BRAF P15056 1/20 0.32
MAPK14 Q16539 2/20 0.32
KLKB1 P03952 2/20 0.32
LMNA P02545 1/20 0.31
TP53 P04637 1/20 0.31
HSP90AA1 P07900 1/20 0.31
GAA P10253 1/20 0.31
PKM P14618 1/20 0.31
XBP1 P17861 1/20 0.31
MAPK1 P28482 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362077 0.93 BRD4 (0.40) BRD4MAPK14
SCHEMBL20157907 0.93 MAP2K2 (0.37) BRD4MAP2K2MAP2K1HDAC10HDAC6
SCHEMBL21564878 0.92 BRD4 (0.34) BRD4MAP2K2MAP2K1HDAC10HDAC6
SCHEMBL20157909 0.92 BRD4 (0.34) BRD4HDAC10HDAC6MAPK14KLKB1
SCHEMBL20157348 0.90 HDAC10 (0.35) BRD4HDAC10HDAC6RAF1BRAF
SCHEMBL21550010 0.89 BRD4 (0.36) BRD4HDAC10HDAC6RAF1BRAF
SCHEMBL20157852 0.88 BRD4 (0.36) BRD4HDAC10HDAC6PKM
SCHEMBL20157755 0.88 BRD4 (0.35) BRD4HDAC10HDAC6RAF1BRAF
SCHEMBL21564928 0.86 BRD4 (0.35) BRD4RAF1BRAF
SCHEMBL21564924 0.86 HDAC10 (0.36) BRD4HDAC10HDAC6TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed